Tesla shares hit eight-month highs despite Q2 revenue decline. Autonomous driving progress, robotaxi potential, and tech ...

Monte Rosa Therapeutics (NASDAQ:GLUE) shares surged in premarket trading Monday, climbing 65.3% to $7.94 after the biotech firm announced a new collaboration with Novartis (NYSE:NVS) to develop ...

CNW/ - Evolve Funds Group Inc. ("Evolve" or the "Manager") is pleased to announce that it has filed a final prospectus with ...